Ikaria Overview
- Founded
- 2005
- Status
- Acquired/Merged
- Employees
- 530
- Latest Deal Type
- M&A
- Financing Rounds
- 8
- Investments
- 1
Ikaria General Information
Description
Operator of an integrated critical care company intended to offer advanced critical care services. The company's critical care services focusses on developing and commercializing innovative therapies enabling to meet the unique and complex medical needs of critically ill patients.
Contact Information
Website
Formerly Known As
ITL Holdings
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Hospitals/Inpatient Services
Other Industries
Other Healthcare Services
Biotechnology
Acquirer
Primary Office
- Perryville III Corporate Park, 53 Frontage Road, Third Floor
- P.O. Box 9001
- Hampton, NJ 08827
- United States
Ikaria Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Ikaria‘s full profile, request access.
Request a free trialIkaria Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialIkaria Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Ikaria‘s full profile, request access.
Request a free trialIkaria Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000 000000000000 | 28-Mar-2007 | 0000000000 | 00000 | Pharmaceuticals |